On May 23, in hopes of boosting its stock price above the minimum $1 per share required to keep its Nasdaq listing, Raytel Medical underwent a one-for-three reverse stock split. Doing so reduced the number of outstanding shares of common stock from
On May 23, in hopes of boosting its stock price above the minimum $1 per share required to keep its Nasdaq listing, Raytel Medical underwent a one-for-three reverse stock split. Doing so reduced the number of outstanding shares of common stock from approximately 8.8 million to 2.9 million. Shareholders have been asked to return their stock certificates representing shares of the old common stock. They will be given cash, based on the May 23 closing price, in lieu of any fractional shares. On May 24, trading closed at $1.8 per share. The upward swing continued, with Raytel closing May 30 at $2.25.
Computed Tomography Study Assesses Model for Predicting Recurrence of Non-Small Cell Lung Cancer
January 31st 2025A predictive model for non-small cell lung cancer (NSCLC) recurrence, based on clinical parameters and CT findings, demonstrated an 85.2 percent AUC and 83.3 percent sensitivity rate, according to external validation testing in a new study.